Professor in Gyn & Obst, co-director and PI in CCBIO, UiB @CCBIO_UiB INOvA @reachoutinova Medical Director, Gynecologic Oncology, Haukeland University hospital
Bergen
Joined April 2009
- Tweets2.6K
- Following961
- Followers773
- Likes4.9K
Line Bjørge retweeted
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A NSGO-OV-UMB1/ENGOT-OV30 trial
➡️buff.ly/410x8gL
@DrLB @mirzacph @VriesElisabeth @thinkCara
#OVCA #Immunotherapy
Line Bjørge retweeted
Me suomalaiset ymmärrämme Ukrainan taistelun vapauden ja itsenäisyyden puolesta. Ukrainan asia on meidän.
We Finns understand Ukraine’s struggle for freedom and independence. Ukraine’s cause is ours.
#SupportUkraine
Line Bjørge retweeted
The wait is over!! We are thrilled to announce that we have chosen Spatial Proteomics as 2024’s Method of the Year! 🥳
For more on Spatial Proteomics and a road map to this special issue, please see this month’s Editorial or read on in this thread.
nature.com/articles/s41592-0…
Line Bjørge retweeted
Dec 5, 2024: Enjoying days in Paris finalising the PARIS project #ovariancancer @bennos, @AnnaVaharautio @WennerbergLab @Gynkreft @reachoutinova @PrecosL @haukeland_no @forskningsradet @medofak_uib @DrLB @CCBIO_UiB @OvaCure_COCT @ERAPerMedPARIS
@erapermedparis
Line Bjørge retweeted
For only the second time in our 179-year history, the editors of Scientific American are endorsing a candidate for president. That person is @KamalaHarris. | Editorial bit.ly/4daH36q
Line Bjørge retweeted
Congratulations to professor Tone M. Norekvål for receiving the #ESC2024 Florence Nightingale award. Here at stage delivering her award lecture. A leading star in nurse-led #research and #education. #ESCCongress @medofak_uib @haukeland_no
Line Bjørge retweeted
In the SHAPE randomized trial in patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy with respect to 3-year pelvic recurrence & was associated with a lower risk of urologic complications. Full trial results: nej.md/4bQqME5
ALT Kaplan–Meier Curves for Pelvic Recurrence
Line Bjørge retweeted
– Det gjør inntrykk å oppleve forskernes entusiasme, både knyttet til senteret og de tre prosjektene som nå starter med støtte fra stiftelsen, sier Anne Marie Haga @annmahg ved @mohnfoundation da TRACE ble offisielt åpnet på mandag. uib.no/igs/168750/%C3%A5pnin…
Line Bjørge retweeted
Job Opportunity 🚨 RTs appreciated
Are you passionate about tumor immune microenvironment & multi-omics in cancer? Our diverse and supportive team is eager to work and learn with and from you 👩🔬👨🔬
🔍 Position: Postdoc in Computational Cancer Biology (1/3)
jobs.helsinki.fi/job/Helsink…
Line Bjørge retweeted
If you're not familiar with @kkariko—and her life- changing discovery against all odds, recognized by the 2023 @NobelPrize, you'll be inspired by this conversation.
The new Ground Truths podcast (link in profile)
Now available @apple and @Spotify
Line Bjørge retweeted
#ICYMI Complications after open and laparoscopic right-sided colectomy with central lymphadenectomy for colon cancer: randomized controlled trial
➡️doi.org/10.1093/bjsopen/zrad…
This study found no significant difference in complications between the two groups. Standardized oncologic right-sided colectomy with central lymphadenectomy along the mesenterial root was performed safely, both open and laparoscopic, with incidence of major complications ranging between 4.6 and 7.9 per cent and no re-operations for anastomotic leakage. Radicality in terms of lymphadenectomy was comparable between the two groups.
Great wory by Kristin B Lygre, Geir E Eide, Havard M Forsmo, Aly Dicko, Kristian E Storli, Frank Pfeffer!
#colorectalcancer @FightCRC #StepUp4CRC #SoMe4Surgery @me4_so #MedTwitter #SurgEd #Surgery @for_surgery @for_surgeons @modern_surgeon @ACPGBI_EduTrain
@dice_europe @BJSAcademy @BJSurgery
@young_bjs @juliomayol @JJEarnshaw
@OUPMedicine @escp_tweets @Haraldsplass
Line Bjørge retweeted
Congratulations to the 2023 literature laureate – Jon Fosse! Watch the very moment Fosse received his Nobel Prize diploma and medal during the 2023 Nobel Prize award ceremony.
#NobelPrize
Line Bjørge retweeted
The Financial Time selected me as one of the 25 most influential women in 2023 🌻
ft.com/womenof2023
#ftwomen2023
Line Bjørge retweeted
NOW OF: The EPI-SURE study of the WID-qEC DNA methylation test versus sonography for detection of uterine cancers in women w/ abnormal uterine bleeding shows that WID-qEC has improved performance compared w/ a combination of imaging index tests.
#gyncsm
thelancet.com/journals/lanon…
Line Bjørge retweeted
#ESMO23: A brighter future for #GynaecologicalCancer? #Research promotion and good partnerships have increased the number of #ClinicalTrials. @CoquardRay: is now time to ensure their accessibility #ESMODailyReporter
👉ow.ly/lcfu50PYUjY
Line Bjørge retweeted
Male Athlete of the Year nominee ✨
Retweet to vote for Jakob Ingebrigtsen 🇳🇴 in the #AthleticsAwards.
Line Bjørge retweeted
For your classroom: Download our free and easy to use Nobel Prize lesson to learn about the detective work by Claudia Goldin, 2023 economic sciences laureate.
Find the lesson “Women in the labour market” here: bit.ly/3ETHcMM
Line Bjørge retweeted
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Line Bjørge retweeted
In patients with platinum-resistant ovarian cancer, clinical trial participation was associated with improved survival ow.ly/M2gi30swNtI
